Bio-Techne news and events in 2026
Bio-Techne develops, manufactures, and supplies biological reagents, analytical instruments, and precision diagnostics. The organization serves the research, diagnostic, and bioprocessing markets, providing tools for protein analysis and spatial biology.
Public (TECH)Biotechnology Research5,001 to 10,000 employeesbio-techne.comLinkedIn
Get Bio-Techne's live signals in Claude or ChatGPT, or by API
What changed at Bio-Techne this week? Use Autobound signals for bio-techne.com.- Dated updates
- 77
- Last event
- Oct 28, 2026
- Open rolesSnapshot Nov 3, 2026
- 20
- Latest SEC filing
- Oct 28, 2026
Source: Autobound Signal API · 77 signals tracked for Bio-Techne · updated
Overview
Bio-Techne by topic
210-Q filings
20open roles
55+signals
14 in the last 90 days
- Glassdoor15+
- LinkedIn15+
- YouTube11
- Employee growth9
- and 1 more sources
Latest events
Latest Bio-Techne events
Showing 10 of 13 events. The Signal API returns all of them.
Get them with one API call- Facility expansionBio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy DevelopmentBio-Techne Corporation announced the opening of a new 10,000-square-foot GMP small molecule manufacturing facility in Bristol, United Kingdom.
- New locationBio-Techne Opens New Customer Experience Centre in Düsseldorf, Strengthening Scientific Exchange and Collaboration with Customers in EuropeBio-Techne has opened a new Customer Experience Centre in Düsseldorf, Germany, to serve as a regional hub for its European customers.
- CertificationBio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate GoalsWith Science Based Targets initiative
- LaunchBio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein PortfolioBio-Techne Corporation has launched new additions to its R&D Systems™ AI-Engineered Designer Protein portfolio, aimed at improving reproducibility in cell therapy and advanced cell culture workflows.
- Earnings
- Integration
- Integration
- Launch
- LaunchLeica Biosystems and Bio-Techne announce the US launch of RNAscope in situ hybridization automation on the BOND-PRIME staining platform.Bio-Techne launches RNAscope in situ hybridization automation on the BOND-PRIME staining platform.
- Launch
Showing 10 of 13 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Bio-Techne with the Signal API
One POST /v1/companies/enrich call with bio-techne.com returns every signal type for Bio-Techne, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bio-techne.com","limit":20}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Companies related to Bio-Techne
Bio-Techne questions
What is the latest news on Bio-Techne?
What is going on with Bio-Techne?
What else does Autobound track for Bio-Techne?
Is Bio-Techne hiring right now?
Page updated , the date of the newest row on this page.
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .